Microvascular pathology in Friedreich cardiomyopathy

Area of Science:

• Cardiovascular Pathology
• Genetics
• Cell Biology

Background:

• Heart disease is a significant complication of Friedreich ataxia (FA).
• FA involves cardiomyocyte hypertrophy, necrosis, inflammation, fibrosis, and disorganized capillaries in the heart.
• Understanding cardiac pathology in FA is crucial for patient management.

Purpose of the Study:

• To quantify capillary and cardiomyocyte numbers in Friedreich ataxia (FA) hearts.
• To investigate the relationship between GAA repeat length and cardiac pathology.
• To explore the role of endothelial-to-mesenchymal transition in FA cardiac fibrosis.

Main Methods:

• Immunohistochemistry using CD34 antibody for capillary counting.
• Analysis of left ventricular wall (LVW) tissue from 41 FA patients and 21 controls.
• Double-label immunofluorescence for CD34 and S100A4 (fibroblast marker).

Main Results:

• FA hearts showed significantly fewer cardiomyocytes compared to controls.
• The ratio of capillaries to cardiomyocytes was higher in FA patients (median 2.0) than controls (median 1.0).
• Longer GAA repeat expansions correlated with younger onset, shorter duration, lower cardiomyocyte counts, and higher capillary-to-fiber ratios.

Conclusions:

• Friedreich ataxia (FA) heart disease is characterized by reduced cardiomyocyte numbers and an increased capillary-to-heart fiber ratio.
• The genetic mutation (GAA repeat length) influences cardiac pathology severity.
• Endothelial-to-mesenchymal transition contributes to cardiac fibrosis in FA, suggesting primary fibrosis as a key pathogenic mechanism.